Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s Sovaldi for hep C
⇨ Spark Therapeutics $ONCE has recruited Federico Mingozzi, a noted gene therapy expert at INSERM and Genethon in France, as chief scientific officer. Mingozzi …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
